Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > money questions

<< Previous

Bullboard Posts

Next >>

Comment by skys1on Aug 31, 2022 3:46pm

127 Views

Post# 34933479

RE:RE:RE:RE:RE:RE:RE:money questions

That's a strong list of positives Dawg, but one you didn't mention is,. "vertually no side effects", per Dr Sherri. This is something I don't believe TLT get's anywhere near the credit it should. I know there are oncologists that won't use the current standard and Ketruda because of the severe side effects it often puts their patients through. I believe this factor alone will cause many oncologists to switch to TLT's ACT when it becomes available.

<< Previous

Bullboard Posts

Next >>

Golden Minerals closes Yoquivo gold-silver project sale